Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 71.38K |
Day Range | - - - |
52 Wk Range | 2.19 - 4.00 |
Market Cap | $326.94M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 2.9% |
Days to Cover | 10.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nautilus Biotechnology (NASDAQ:NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
There is no analysis for Nautilus Biotechnology.
Nautilus Biotechnology has a consensus price target of $4.25.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $2.61 last updated July 19, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.